间质干细胞市场规模、份额及成长分析（按产品、来源、适应症、应用及地区划分）－产业预测，2025-2032年

预计到 2023 年，全球间质干细胞市场规模将达到 36 亿美元，到 2024 年将成长至 40.5 亿美元，到 2032 年将成长至 104.7 亿美元，在预测期（2025-2032 年）内，复合年增长率为 12.6%。

间质干细胞（MSCs）的全球市场正经历显着成长，这主要得益于其在再生医学、组织工程和免疫调节领域公认的治疗潜力。 MSCs对组织修復和再生至关重要，并具有分化成多种细胞类型的能力，包括骨细胞、软骨细胞和脂肪细胞。慢性疾病的增加、细胞疗法需求的增长以及MSCs在整形外科、神经科、肿瘤科和皮肤科等广泛领域的治疗应用不断扩展，共同推动了这一市场扩张。干细胞库和生物製程技术的进步，以及生物技术公司、研究机构和医疗机构之间的合作，正在促进临床试验的核准。然而，持续的创新和市场发展需要解决伦理问题和监管的复杂性。

全球间质干细胞市场驱动因素

包括心血管疾病、骨关节炎、自体免疫疾病和神经系统疾病在内的慢性疾病发生率不断上升，正显着推动全球间质干细胞市场的成长。间质干细胞（MSCs）具有卓越的组织再生能力和免疫调节能力，使其成为治疗这些疾病的一种极具前景的选择。随着越来越多的患者寻求创新的再生疗法，基于MSCs的治疗方法需求预计将显着增长，这反映出人们不断追求有效治疗各种慢性疾病的方案。这种对先进治疗方法日益增长的需求有望进一步推动MSC领域的发展和投资。

限制全球间质干细胞市场的因素

全球间间质干细胞市场面临许多限制因素，主要源自于研发和治疗治疗方法高成本。间质干细胞的生产过程需要专业的实验室、无尘室环境、先进的设备和训练有素的人员，以确保细胞的活力、纯度和无菌性。此外，细胞分离、扩增和冷冻保存等步骤耗时且耗力。这些因素导致治疗费用居高不下，造成患者经济负担，尤其是在缺乏健保体系的发展中地区。因此，儘管间质干细胞治疗方法具有显着的治疗优势，但其推广应用仍可能受到阻碍。

全球间质干细胞市场趋势

全球间间质干细胞(MSC) 市场正呈现出向再生医学和个人化医疗发展的明显趋势，这主要得益于 MSC 修復和再生受损组织的卓越潜力。这种转变在肌肉骨骼疾病、心血管疾病、神经系统疾病和自体免疫疾病的治疗中尤其显着，基于 MSC 的治疗方法正日益受到医疗机构的青睐。对细胞特性的深入研究、分离技术的改进以及可扩展生产过程的建立，正为更精准的治疗方法铺平道路。此外，预测模型和人工智慧在患者选择和治疗方案製定中的日益普及，正在优化 MSC 的应用，有望带来更好的临床疗效并最大限度地减少副作用。这凸显了市场对个人化治疗方案日益增长的需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球间质干细胞市场规模（依产品划分）、复合年增长率（2025-2032 年）

• 市场概览
• 细胞和细胞株
• 套件、培养基和试剂
• 其他的

全球间质干细胞市场规模（依来源划分）、复合年增长率（2025-2032 年）

• 市场概览
• 骨髓间质干细胞
• 脂肪组织来源的间质干细胞
• 脐带/胎盘来源的间质干细胞
• 其他的

全球间质干细胞市场规模（依适应症划分）、复合年增长率（2025-2032 年）

• 市场概览
• 骨/软骨修復
• 心血管疾病
• 发炎/免疫性疾病
• 肝病
• 癌症
• 移植物抗宿主疾病（GvHD）及其他适应症

全球间质干细胞市场规模（按应用领域划分），复合年增长率（2025-2032 年）

• 市场概览
• 疾病模型
• 药物发现与开发
• 干细胞库
• 组织工程
• 毒理学研究

全球间质干细胞市场规模（按地区划分）、复合年增长率（2025-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Inc.
• Merck KGaA
• Lonza Group Ltd.
• Cyagen Biosciences Inc.
• PromoCell GmbH
• Axol Bioscience Ltd.
• Cellcolabs Clinical Ltd.
• Cell Applications Inc.
• Mesoblast Ltd.
• Cynata Therapeutics
• Orgenesis Inc.
• Stempeutics Research Pvt. Ltd.
• BioRestorative Therapies
• ScienCell Research Laboratories Inc.
• Takara Bio Inc.
• Takara Bio Inc.
• BioTime Inc.
• PLURI Inc.
• Cell Tech Pharmed

结论与建议

Global Mesenchymal Stem Cells Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 4.05 billion in 2024 to USD 10.47 billion by 2032, growing at a CAGR of 12.6% during the forecast period (2025-2032).

The global market for mesenchymal stem cells (MSCs) is witnessing significant growth, fueled by their recognized therapeutic potential in regenerative medicine, tissue engineering, and immunomodulation. MSCs are pivotal for tissue repair and regeneration, with the ability to differentiate into various cell types such as bone, cartilage, and fat. This market expansion is driven by the rising incidence of chronic diseases, increased demand for cell-based therapies, and the broadening applications of MSC treatments across fields like orthopedics, neurology, oncology, and dermatology. Technological advancements in stem cell banking and bioprocessing, alongside collaborative efforts among biotechnology firms, research institutions, and healthcare providers, are enhancing clinical trial approvals. However, challenges such as ethical issues and regulatory complexities must be addressed for sustained innovation and market development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mesenchymal Stem Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mesenchymal Stem Cells Market Segments Analysis

Global Mesenchymal Stem Cells Market is segmented by Product, Source, Indication, Application and region. Based on Product, the market is segmented into Cells & Cell Lines, Kits, Media & Reagents and Others. Based on Source, the market is segmented into Bone Marrow-derived MSCs, Adipose Tissue-derived MSCs, Umbilical Cord / Placental MSCs and Others. Based on Indication, the market is segmented into Bone & Cartilage Repair, Cardiovascular Diseases, Inflammatory & Immunological Diseases, Liver Diseases, Cancer and GvHD & Other Indications. Based on Application, the market is segmented into Disease Modeling, Drug Discovery & Development, Stem Cell Banking, Tissue Engineering and Toxicology Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mesenchymal Stem Cells Market

The increasing occurrence of chronic conditions, including cardiovascular issues, osteoarthritis, autoimmune disorders, and neurological diseases, significantly fuels growth in the Global Mesenchymal Stem Cells market. Mesenchymal stem cells (MSCs) possess the remarkable ability to regenerate damaged tissues and modulate immune responses, positioning them as a promising therapeutic alternative for these conditions. As more individuals seek innovative regenerative treatment options, the demand for MSC-based therapies is expected to rise substantially, reflecting the ongoing pursuit of effective solutions for managing various chronic ailments. This escalating need for advanced therapies will likely catalyze further advancements and investments in the MSC sector.

Restraints in the Global Mesenchymal Stem Cells Market

The Global Mesenchymal Stem Cells market faces significant constraints primarily due to the high costs associated with therapy development and administration. The process of manufacturing mesenchymal stem cells requires specialized laboratories, cleanroom environments, advanced equipment, and a highly trained workforce to ensure the viability, purity, and sterility of the cells. Additionally, the procedures involved in cell isolation, expansion, and cryopreservation are both time-consuming and resource-intensive. These factors contribute to elevated treatment costs, which can pose challenges for patients, particularly in developing regions lacking reimbursement options. Consequently, the adoption of MSC-based therapies, despite their notable therapeutic advantages, can be hindered.

Market Trends of the Global Mesenchymal Stem Cells Market

The Global Mesenchymal Stem Cells (MSC) market is witnessing a pronounced trend towards regenerative and personalized medicine, driven by the remarkable potential of MSCs to repair and regenerate damaged tissues. This shift is particularly evident in the treatment of musculoskeletal disorders, cardiovascular diseases, neurological problems, and autoimmune disorders, as MSC-based therapies gain traction among healthcare providers. Enhanced research into cellular characteristics, improved isolation methods, and scalable manufacturing processes are paving the way for more precision-focused therapies. Moreover, the integration of predictive modeling and artificial intelligence into patient selection and therapeutic planning is refining MSC applications, promising superior clinical outcomes and minimizing side effects, thereby underscoring a growing preference for individualized treatment approaches within the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Mesenchymal Stem Cells Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cells & Cell Lines
• Kits, Media & Reagents
• Others

Global Mesenchymal Stem Cells Market Size by Source & CAGR (2025-2032)

• Market Overview
• Bone Marrow-derived MSCs
• Adipose Tissue-derived MSCs
• Umbilical Cord / Placental MSCs
• Others

Global Mesenchymal Stem Cells Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Bone & Cartilage Repair
• Cardiovascular Diseases
• Inflammatory & Immunological Diseases
• Liver Diseases
• Cancer
• GvHD & Other Indications

Global Mesenchymal Stem Cells Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Modeling
• Drug Discovery & Development
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies

Global Mesenchymal Stem Cells Market Size & CAGR (2025-2032)

• North America (Product, Source, Indication, Application)
  • US
  • Canada
• Europe (Product, Source, Indication, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Source, Indication, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Source, Indication, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Source, Indication, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axol Bioscience Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellcolabs Clinical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Applications Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynata Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orgenesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stempeutics Research Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRestorative Therapies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PLURI Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Tech Pharmed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations